Salacia reticulata WIGHT (Kothalahimbatu): A Review of botany, phytochemistry and pharmacology.

Show simple item record

dc.contributor.author Arunakumara, K.K.I.U
dc.contributor.author Subasinghe, S
dc.date.accessioned 2023-02-22T04:01:02Z
dc.date.available 2023-02-22T04:01:02Z
dc.date.issued 2010
dc.identifier.citation Hettiarachchi, R.H.A.N., & Walpola, B.C. (2016). An efficient microbiological growth media for screening phosphate solubilizing microorganisms. Proceeding of the 13th Academic Session, University of Ruhuna, p. 121. en_US
dc.identifier.issn 1391-3646
dc.identifier.uri http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/11358
dc.description.abstract Salacia reticulata is a large woody climbing shrub naturally found in Sri Lanka and Southern region of India. It is widely used in treating diabetes, a chronic disorder in metabolism of carbohydrates, proteins and fat due to absolute or relative deficiency of insulin secretion with/without varying degree of insulin resistance. The decoction of S. reticulata roots is also used in the treatment of gonorrhea, rheumatism, skin diseases, haemorrhoids, itching and swelling, asthma, thirst, amenorrhea and dysmenorrheal. Presence of mangiferin (a xanthone from the roots), kotalanol and salacinol (from the roots and stems) have been identified as the antidiabetic principles of S. reticulata. Chemical constituents such as 1,3- diketones, dulcitol and leucopelargonidin, iguesterin, epicatechin, phlobatannin and glycosidal tannins, triterpenes, and 30-hydroxy-20(30) dihydroisoiguesterin, hydroxyferruginol, lambertic acid, kotalagen in 16-acetate, 26-hydroxy-1,3-friedelanedione, maytenfolic acid have also been detected in the roots of S. reticulata. The antidiabetic property of Salacia is basically attributed to the inhibitory activity of in testinal enzymes (α-glucosidase and α-amylase). Inhibition of intestinal enzymes delays glucose absorp tion into the blood and suppresses postprandial hyperglycemia, resulting in improved glycemic control. Furthermore, mangiferin has been reported to inhibit aldose reductase activity delaying the onset or progression of diabetic complications. Though diabetes has now become an epidemic affecting millions of people worldwide, neither insulin nor other modern pharmaceuticals has been shown to modify the course of diabetic complications mainly due to the multifactorial basis that involves both genetic and environmental risk factors. Therefore, effort is being devoted to find new therapeutics aimed at multi ple targets, which has become a new paradigm in drug discovery. In this context, the discoveries on S. reticulata have lead to increase the consumption of the species across the world and it has now become a subject of broad studies for diabetes management en_US
dc.language.iso en en_US
dc.publisher University of Ruhuna, Sri Lanka en_US
dc.subject Salacia reticulata en_US
dc.subject Mangiferin en_US
dc.subject Kotalanol en_US
dc.subject Salacinol en_US
dc.title Salacia reticulata WIGHT (Kothalahimbatu): A Review of botany, phytochemistry and pharmacology. en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account